Concepedia

Scott Moseley

SM

15

Publications

1.3K

Citations

14

H-Index

2004

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Shriners Hospitals for Children - Erie

Barnes-Jewish Hospital

University of Manitoba

University of Würzburg

Scott Moseley is an author at Alexion Pharmaceuticals (United States) specializing in medicine, viral hepatitis, and hepatitis c.

Top concepts

Publications per year

2004–2020

15

Publications

15

Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia

Michael P. Whyte, Cheryl R. Greenberg, Keiichi Ozono et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 259 citations · Full text

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery et al. · Neurology · 2016 · 210 citations · Full text

Asfotase alfa therapy for children with hypophosphatasia

Michael P. Whyte, Katherine L. Madson, Dawn Phillips et al. · JCI Insight · 2016 · 166 citations · Full text

Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia

Priya S. Kishnani, Cheryl R. Greenberg, Frank Rauch et al. · Bone · 2018 · 142 citations · Full text

Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial

Michael P. Whyte, Jill H. Simmons, Scott Moseley et al. · The Lancet Diabetes & Endocrinology · 2018 · 137 citations

, , +5

Rows per page

1–5 of 15